Successful treatment of catecholaminergic polymorphic ventricular tachycardia with flecainide: A case report and review of the current literature

Europace

Volumn 13, Issue 6, 2011, Pages 897-901

  Pott, Christian ^a   Dechering, Dirk G ^a   Reinke, Florian ^a   Muszynski, Adam ^a   Zellerhoff, Stephan ^a   Bittner, Alex ^a   Köbe, Julia ^a   Wasmer, Kristina ^a   Schulze Bahr, Eric ^a   Mönnig, Gerold ^a   Kotthoff, Stefan ^a   Eckardt, Lars ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BISOPROLOL; FLECAINIDE; RYANODINE RECEPTOR 2; VERAPAMIL;

ADD ON THERAPY; BRADYCARDIA; CASE REPORT; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; DEFIBRILLATION; DEFIBRILLATOR; DRUG DOSE ESCALATION; DRUG DOSE REDUCTION; DRUG DOSE TITRATION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXERCISE TEST; GENETIC SCREENING; HEART VENTRICLE FIBRILLATION; HOLTER MONITORING; HUMAN; LOW DRUG DOSE; MALE; MISSENSE MUTATION; PHYSICAL DISEASE; PHYSICAL STRESS; PRIORITY JOURNAL; RESUSCITATION; REVIEW; SCHOOL CHILD;

ADRENERGIC BETA-ANTAGONISTS; ANTI-ARRHYTHMIA AGENTS; CALCIUM CHANNEL BLOCKERS; CHILD; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; DRUG THERAPY, COMBINATION; ELECTROCARDIOGRAPHY; FLECAINIDE; HUMANS; MALE; MUTATION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; TACHYCARDIA, VENTRICULAR; TREATMENT OUTCOME; VERAPAMIL;

EID: 79957896999     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq517     Document Type: Review

References (15)

1. Leenhardt A, Lucet V, Denjoy I, Grau F, Ngoc DD, Coumel P. Catecholaminergic polymorphic ventricular tachycardia in children. A 7-year follow-up of 21 patients. Circulation 1995;91:1512-9.
2. Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation 2002;106:69-74. (Pubitemid 34747444)
3. Sumitomo N, Harada K, Nagashima M, Yasuda T, Nakamura Y, Aragaki Y et al. Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death. Heart 2003;89:66-70. (Pubitemid 36044293)
4. Priori SG, Napolitano C, Tiso N, Memmi M, Vignati G, Bloise R et al. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia. Circulation 2001;103:196-200. (Pubitemid 32095402)
5. Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001;69:1378-84. (Pubitemid 33124218)
6. Wilde AA, Bhuiyan ZA, Crotti L, Facchini M, De Ferrari GM, Paul T et al. Left cardiac sympathetic denervation for catecholaminergic polymorphic ventricular tachycardia. N Engl J Med 2008;358:2024-9. (Pubitemid 351656456)
7. Mohamed U, Gollob MH, Gow RM, Krahn AD. Sudden cardiac death despite an implantable cardioverter-defibrillator in a young female with catecholaminergic ventricular tachycardia. Heart Rhythm 2006;3:1486-9. (Pubitemid 44849373)
8. Watanabe H, Chopra N, Laver D, Hwang HS, Davies SS, Roach DE et al. Flecainide prevents catecholaminergic polymorphic ventricular tachycardia in mice and humans. Nat Med 2009;15:380-3.
9. Biernacka EK, Hoffman P. Efficacy of flecainide in a patient with catecholaminergic polymorphic ventricular tachycardia. Europace 2010;13:129-30.
10. Milberg P, Pott C, Fink M, Frommeyer G, Matsuda T, Baba A et al. Inhibition of the Na+/Ca2+ exchanger suppresses torsades de pointes in an intact heart model of long QT syndrome-2 and long QT syndrome-3. Heart Rhythm 2008;5:1444-52.
11. Pogwizd SM, Bers DM. Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc Med 2004;14:61-6. (Pubitemid 38340848)
12. Sipido KR, Volders PG, de Groot SH, Verdonck F, Van de Werf F, Wellens HJ et al. Enhanced Ca2+ release and Na+/Ca2+ exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation 2000;102:2137-44.
13. Pott C, Goldhaber JI, Philipson KD. Homozygous overexpression of the Na+-Ca2+ exchanger in mice: evidence for increased transsarcolemmal Ca2+ fluxes. Ann N Y Acad Sci 2007;1099:310-4. (Pubitemid 47092585)
14. Pott C, Philipson KD, Goldhaber JI. Excitation-contraction coupling in Na+-Ca2+ exchanger knockout mice: reduced transsarcolemmal Ca2+ flux. Circ Res 2005;97: 1288-95.
15. Pratt CM. The cardiac arrhythmia suppression trial. Introduction: the aftermath of the CAST-a reconsideration of traditional concepts. Am J Cardiol 1990;65:1B-2B. (Pubitemid 20031278)